These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin. Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871 [TBL] [Abstract][Full Text] [Related]
4. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360 [TBL] [Abstract][Full Text] [Related]
5. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor. Li YC; Zhang X; Melton R; Ganu V; Gonnella NC Biochemistry; 1998 Oct; 37(40):14048-56. PubMed ID: 9760240 [TBL] [Abstract][Full Text] [Related]
6. Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide. Streltsov VA; Chandana Epa V; James SA; Churches QI; Caine JM; Kenche VB; Barnham KJ Chem Commun (Camb); 2013 Dec; 49(97):11364-6. PubMed ID: 24161993 [TBL] [Abstract][Full Text] [Related]
7. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity. Pavlovsky AG; Williams MG; Ye QZ; Ortwine DF; Purchase CF; White AD; Dhanaraj V; Roth BD; Johnson LL; Hupe D; Humblet C; Blundell TL Protein Sci; 1999 Jul; 8(7):1455-62. PubMed ID: 10422833 [TBL] [Abstract][Full Text] [Related]
8. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors. Di Pizio A; Laghezza A; Tortorella P; Agamennone M ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight into the inhibition of matrix metalloproteinases by platinum substrates. Arnesano F; Boccarelli A; Cornacchia D; Nushi F; Sasanelli R; Coluccia M; Natile G J Med Chem; 2009 Dec; 52(23):7847-55. PubMed ID: 19757821 [TBL] [Abstract][Full Text] [Related]
10. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1. Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of metalloproteinases types 2 and 3 reveal differences in the dynamic behavior of the S1' binding pocket. de Oliveira CA; Zissen M; Mongon J; McCammon JA Curr Pharm Des; 2007; 13(34):3471-5. PubMed ID: 18220784 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases. Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835 [TBL] [Abstract][Full Text] [Related]
13. Solution structures of stromelysin complexed to thiadiazole inhibitors. Stockman BJ; Waldon DJ; Gates JA; Scahill TA; Kloosterman DA; Mizsak SA; Jacobsen EJ; Belonga KL; Mitchell MA; Mao B; Petke JD; Goodman L; Powers EA; Ledbetter SR; Kaytes PS; Vogeli G; Marshall VP; Petzold GL; Poorman RA Protein Sci; 1998 Nov; 7(11):2281-6. PubMed ID: 9827994 [TBL] [Abstract][Full Text] [Related]
14. Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy. Gonnella NC; Li YC; Zhang X; Paris CG Bioorg Med Chem; 1997 Dec; 5(12):2193-201. PubMed ID: 9459017 [TBL] [Abstract][Full Text] [Related]
15. A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibition. Johnson LL; Pavlovsky AG; Johnson AR; Janowicz JA; Man CF; Ortwine DF; Purchase CF; White AD; Hupe DJ J Biol Chem; 2000 Apr; 275(15):11026-33. PubMed ID: 10753905 [TBL] [Abstract][Full Text] [Related]
16. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. Campestre C; Agamennone M; Tortorella P; Preziuso S; Biasone A; Gavuzzo E; Pochetti G; Mazza F; Hiller O; Tschesche H; Consalvi V; Gallina C Bioorg Med Chem Lett; 2006 Jan; 16(1):20-4. PubMed ID: 16242329 [TBL] [Abstract][Full Text] [Related]
17. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453. Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129 [TBL] [Abstract][Full Text] [Related]
18. Identification of highly potent and selective MMP2 inhibitors addressing the S1' subsite with d-proline-based compounds. Lenci E; Innocenti R; Di Francescantonio T; Menchi G; Bianchini F; Contini A; Trabocchi A Bioorg Med Chem; 2019 May; 27(9):1891-1902. PubMed ID: 30926311 [TBL] [Abstract][Full Text] [Related]
19. Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus. Crossley EL; Aitken JB; Vogt S; Harris HH; Rendina LM Angew Chem Int Ed Engl; 2010 Feb; 49(7):1231-3. PubMed ID: 20077549 [No Abstract] [Full Text] [Related]